Whitney & Co’s Ionis Pharmaceuticals IONS Stock Holding History

Whitney & Co’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-200	Closed	-$8K	–	544
2018 Q2	$8K	Hold	200	–	–	﹤0.01%	254
2018 Q1	$9K	Buy	+200	New	+$10.2K	﹤0.01%	249

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Whitney & Co's IONS Position: Q3 2018 in Review

Whitney & Co sold out of Ionis Pharmaceuticals (IONS) in Q3 2018, closing a stake of 200 shares — an estimated $8K sold.

Whitney & Co first reported a position in IONS in Q1 2018 and held it in 2 quarters. The position peaked at $9K in Q1 2018. 322 funds tracked by Wall St. Rank hold IONS as of Q3 2018.

Whitney & Co reported no remaining Ionis Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Whitney & Co sold 200 Ionis Pharmaceuticals shares in Q3 2018, an estimated $8K.
Whitney & Co first reported a position in Ionis Pharmaceuticals in Q1 2018 and held it in 2 quarters.
Whitney & Co's Ionis Pharmaceuticals position peaked at $9K in Q1 2018.
322 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2018.

Based on Whitney & Co's 13F filing for Q3 2018, filed 13 Nov 2018.